Biden forming nonprofit to focus on cancer issues after leaving White House

Outgoing Vice President Joe Biden will continue to advocate for changes in cancer research and treatment once he leaves political office by creating a new nonprofit organization.

“I’m going to begin a national conversation and get Congress and advocacy groups in to make sure these treatments are accessible to everyone, including these vulnerable underserved populations, and that we have a more rational way of paying for them while promoting innovation,” Biden said in a Washington Post interview.

Biden was put in charge of President Barack Obama’s cancer “moonshot” after his son Beau died of brain cancer in 2015. He plans on continuing the objectives of that initiative—like finding new ways to improve oncology treatment—while expanding the mission with new priorities, like lowering the cost of cancer drugs.

Pharmaceutical companies are already taking notice of Biden’s plans. Read the full article below: 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The FTC alleges that pharmacy benefit managers have set up a system where they get rich, while patients are forced to pay rising insulin costs. The agency also called out drug manufacturers such as Eli Lilly, Sanofi and Novo Nordisk, saying their own actions have raised serious concerns.

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

Trimed Popup
Trimed Popup